NCT06511141 2026-03-12
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Axonics, Inc.
Phase NA Recruiting
Clinical Trials
16 trialsNCT06051942 2026-01-28
PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs
PROCEPT BioRobotics
Phase NA Active not recruiting
NCT04272216 2025-09-09
RAVI Registry
Terumo Medical Corporation
Completed
NCT04853914 2025-06-05
Evaluation of the Safety of the Treatment of Benign Prostatic Hyperplasia by High Intensity Focused Ultrasound.
EDAP TMS S.A.
Phase NA Completed
NCT04693507 2024-07-23
TEACh
Antev Ltd.
Phase 2 Completed
NCT04446429 2021-12-10
Anti-Androgen Treatment for COVID-19
Applied Biology, Inc.
Phase NA Completed
NCT01194960 2020-10-19
TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)
Oxford BioMedica
Phase 2 Terminated
NCT02916537 2017-11-06
A Phase 1 Trial for Evaluation of the Safety, Pharmacokinetics, and [18F] Radiation Dosimetry of CTT1057
Cancer Targeted Technology
Phase 1 Completed
NCT00883909 2017-07-11
ARI103094-Follow-Up Study for REDUCE Study Subjects
GlaxoSmithKline
Completed
NCT01337258 2017-05-30
Economic Analyses of the REDUCE Trial
GlaxoSmithKline
Completed
NCT01371513 2017-05-22
RESPECT
GlaxoSmithKline
Completed
NCT00375765 2017-01-19
Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer
GlaxoSmithKline
Phase 4 Completed
NCT01767363 2016-11-09
WEUSKOP5723: Prostate Cancer Study
GlaxoSmithKline
Completed
NCT02496442 2015-07-14
Aqueduct Irrigation System Clinical Protocol: Medical Device Investigational Plan
Flowmed
Phase NA Unknown
NCT00822952 2014-03-31
PMI
Artann Laboratories
Completed
NCT00400894 2007-02-05
Annexin A3 (ANXA3) as Protein-Based Marker for Non-Invasive Molecular Diagnostics of Prostate Carcinoma
ProteoSys AG
Unknown